“99%+ purity” appears on nearly every research peptide listing, including ours. It is a meaningful specification, but only if you know what the remaining fraction is made of and why it matters for the experiment you are running. This article explains where impurities come from, what kinds exist, how each affects laboratory work, and why the difference between 95% and 99% is larger than it looks.
Where Impurities Come From
Research peptides are made by solid-phase synthesis: amino acids are added one at a time to a growing chain anchored to a resin, with protecting groups removed and reattached at each cycle. Every cycle is efficient but not perfect. If a 15-residue peptide is built with 99% efficiency per step, only about 86% of chains come out with every residue in place; the rest carry errors. Purification by preparative HPLC removes most of the failures, and the final purity number tells you how well that worked.
The main impurity classes are:
- Deletion sequences: chains missing one residue because a coupling step failed. These are the most common impurity and the hardest to separate, because a peptide missing one small residue behaves almost like the full sequence on HPLC.
- Truncated sequences: chains that stopped growing early.
- Incompletely deprotected peptides: chains still carrying a protecting group on a side chain.
- Oxidized or modified residues: methionine sulfoxide, deamidated asparagine, isomerized aspartate, formed during synthesis, cleavage, or storage.
- Diastereomers: a residue that flipped from the L- to the D-form during coupling.
Beyond peptide-related impurities, lyophilized material also contains counter-ions (acetate or trifluoroacetate) and water. These are not counted in HPLC purity at all; see What a COA Tells You for why that distinction matters.
Why 99% Is Different From 95%
The arithmetic is unkind to lower purities. At 95%, one molecule in twenty is something other than the target. At 99%, it is one in a hundred. That is a five-fold difference in impurity load, not a four-percentage-point one.
What makes this matter biologically is that impurities are not inert. A deletion sequence of a receptor agonist may be a weaker agonist, a full antagonist, or inactive; a truncated fragment may bind a different site; an oxidized methionine can abolish activity entirely. In a receptor assay, 5% of a mixture with unknown pharmacology is a meaningful confound. In a tissue-culture experiment run for weeks, impurities that aggregate or that cells process differently can shift results in ways no control accounts for.
The consequences grow with sequence length and complexity. For a short tripeptide such as GHK-Cu, there are few possible deletion products. For a 39-residue acylated incretin analog such as GLP1-S, the number of plausible near-miss sequences is large, and some of them will have receptor activity of their own. The longer the peptide, the more a high purity specification is worth.
Purity and Reproducibility
The most practical reason to insist on high purity is not a single experiment but the next one. A laboratory that buys 95% material from one lot and 97% from the next is working with two different impurity profiles, and any change in results between lots is ambiguous. At 99%+, the impurity fraction is small enough that lot-to-lot variation in that fraction is unlikely to move an endpoint, which is what reproducibility requires.
This also applies across suppliers. Two vials labeled with the same compound name and the same nominal purity can differ substantially if one supplier’s number comes from a well-integrated chromatogram and the other’s from a generous baseline. The chromatogram on the Certificate of Analysis, not the headline number, is what lets you compare. Our article What Does 99% Purity Actually Mean? explains how to read one.
Purity Is Not the Whole Story
Two other specifications sit alongside purity and are easy to overlook.
Identity. A peptide can be 99.5% pure and be the wrong peptide. Mass spectrometry confirms that the main peak has the expected mass; without it, purity is a measurement of an unknown.
Stability after receipt. Purity is measured on the test date. A 99% peptide stored warm or reconstituted and kept for months will not stay at 99%. The impurities that form in storage (oxidation, deamidation, isomerization) are the same ones listed above, now generated in your laboratory rather than the manufacturer’s. Storage and reconstitution technique protect the purity you paid for; this article covers the chemistry.
What Pristine Aminos Specifies
Every peptide we sell is tested by an independent laboratory for HPLC purity and mass-spectrometric identity on a per-lot basis, with a minimum specification of 99% purity for single compounds. The chromatogram and mass spectrum are published with each product. For blends, each component is identified individually; see Peptide Blends Explained for why that matters. Details of the testing process are in Inside Third-Party Peptide Testing.
Summary
Purity describes how much of the peptide-related material is the intended sequence. Impurities are mostly near-miss sequences with their own, unknown pharmacology, so the gap between 95% and 99% is a five-fold difference in confounding material. High purity matters most for long and complex sequences and for any work that must be reproduced. Pair it with mass-spectrometric identity and sound storage, and the material stops being a variable in your experiment.
Browse third-party-tested research peptides in the Pristine Aminos catalog.
For laboratory and research use only. Not for human or veterinary use, consumption, or therapeutic application.



